Dow Down 0.36% Nasdaq Down 0.53%

NewLink Genetics Corporation (NLNK)

-NasdaqGM
27.40 Up 0.72(2.70%) Sep 12, 4:00PM EDT
Prev Close:26.68
Open:28.12
Bid:25.25 x 100
Ask:29.91 x 200
1y Target Est:36.25
Beta:-0.64
Next Earnings Date:N/A
Day's Range:26.69 - 28.16
52wk Range:16.00 - 53.48
Volume:345,031
Avg Vol (3m):364,991
Market Cap:764.71M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NLNKUp 2.70%764.71M
LLYUp 0.14%69.95B
TEVAUp 1.20%44.46B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):673.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.57
Quarterly EPS Est (Sep-14) :-0.41
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback